1-8 of 8
Catherine Leith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Versican (VCAN) Proteolysis Predicts Survival in Multiple Myeloma (MM) after High Dose Therapy and Autologous Hematopoietic Cell Transplantation (HDT/AHCT)

Binod Dhakal, MBBS, Muhammad Umair Mushtaq, MD, Ashley Cunningham, MD, Athanasios Papadas, MD, Adam Pagenkopf, BS, Joshua Wiesner, Catherine Leith, MBBChir, Peiman Hematti, MD, Parameswaran Hari, MBBS, MD, Natalie Scott Callander, MD, Fotis Asimakopoulos, PhDMBBChir,
Journal: Blood
Blood (2019) 134 (Supplement_1): 3088.
https://doi.org/10.1182/blood-2019-127565
Published: 2019
Journal Articles

Versican (VCAN) Proteolysis Predicts T-Cell Infiltration in Myeloma Bone Marrow Post- Autologous Stem Cell Transplant (ASCT)

Adam Pagenkopf, Binod Dhakal, MBBS, Chelsea L. Hope, PhD, Athanasios Papadas, MD, Michael G Johnson, PhD, Bradley Nagel, Elena Kurudza, Samik Partha, Bianca Ruffolo, Catherine Leith, MBBChir, Shigeki Miyamoto, PhD, Peiman Hematti, MD, Parameswaran Hari, MD MRCP, MS, Natalie Scott Callander, MD, Fotios Asimakopoulos, PhDMBBChir,
Journal: Blood
Blood (2017) 130 (Supplement 1): 1756.
https://doi.org/10.1182/blood.V130.Suppl_1.1756.1756
Published: 2017
Journal Articles

Immunoregulatory roles of versican proteolysis in the myeloma microenvironment

Brief Report
Chelsea Hope, Simon Foulcer, Justin Jagodinsky, Sarah X. Chen, Jeffrey L. Jensen, Sanjay Patel, Catherine Leith, Ioanna Maroulakou, Natalie Callander, Shigeki Miyamoto, Peiman Hematti, Suneel S. Apte, Fotis Asimakopoulos
Journal: Blood
Blood (2016) 128 (5): 680–685.
https://doi.org/10.1182/blood-2016-03-705780
Published: 2016
Includes: Supplemental data
Journal Articles

TPL2 kinase regulates the inflammatory milieu of the myeloma niche

Chelsea Hope, Samuel J. Ollar, Erika Heninger, Ellen Hebron, Jeffrey L. Jensen, Jaehyup Kim, Ioanna Maroulakou, Shigeki Miyamoto, Catherine Leith, David T. Yang, Natalie Callander, Peiman Hematti, Marta Chesi, P. Leif Bergsagel, Fotis Asimakopoulos
Journal: Blood
Blood (2014) 123 (21): 3305–3315.
https://doi.org/10.1182/blood-2014-02-554071
Published: 2014
Includes: Supplemental data
Journal Articles

Molecular Pathways That Determine the Activation State of Macrophages within the Myeloma Niche

Chelsea Hope, Ellen Hebron, Jaehyup Kim, MD, Jeff Jensen, Claire Flanagan, Neehar Bhatia, Catherine Leith, MBBChir, Ioanna Maroulakou, PhD, Constantine S. Mitsiades, MD, PhD, Shigeki Miyamoto, PhD, Natalie Callander, MD, Peiman Hematti, MD, Fotis Asimakopoulos, MBBChir, PhD
Journal: Blood
Blood (2012) 120 (21): 443.
https://doi.org/10.1182/blood.V120.21.443.443
Published: 2012
Journal Articles

Identification of Potential Prognostic Biomarkers in Mantle Cell Lymphoma by Array-Based Quantitative Nuclease Protection Assay

David T Yang, MD, Gene R Shaw, MD, PhD, Kreg M Grindle, Songwon Seo, Catherine Leith, MBBChir, Ken H Young, Brad Kahl, MD
Journal: Blood
Blood (2010) 116 (21): 2007.
https://doi.org/10.1182/blood.V116.21.2007.2007
Published: 2010
Journal Articles

Phase II Trial of Bortezomib Combined with Weekly Doxorubicin and Oral Dexamethasone for Relapsed or Refractory Multiple Myeloma (MM): Effect of NF-κB Activation on Response.

Natalie S. Callander, MD, Shigeki Miyamoto, PhD, Brad Kahl, MD, Stephanie Markovina, Martha Raschko, Jae Werndl, Catherine Leith, MBBDir, Alice McCoy, MD
Journal: Blood
Blood (2006) 108 (11): 3545.
https://doi.org/10.1182/blood.V108.11.3545.3545
Published: 2006
Journal Articles

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Clinical Trials & Observations
Rita M. Braziel, Daniel A. Arber, Marilyn L. Slovak, Margaret L. Gulley, Catherine Spier, Carl Kjeldsberg, Joseph Unger, Thomas P. Miller, Raymond Tubbs, Catherine Leith, Richard I. Fisher, Thomas M. Grogan
Journal: Blood
Blood (2001) 97 (12): 3713–3720.
https://doi.org/10.1182/blood.V97.12.3713
Published: 2001